Loading stock data…
Ardent Health, Inc. (ARDT)
$9.73+0.37 (+3.95%)
Market ClosedLast close Jun 26
Ardent Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ardent Health, Inc. in the Healthcare sector is trading at $9.79 with a market capitalization of $1.1B. Wall Street consensus targets $12.41 (11 analysts), implying a +26.8% move over the next 12 months. The stock is currently 37% below its 52-week high of $15.48, remaining 4.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +26.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.60B↓ | $1.61B↑ | $1.58B↓ | $1.65B↑ | $1.50B |
| Gross Profit | $671.89M↓ | $676.16M↑ | $623.90M↓ | $702.94M↑ | $580.73M |
| Operating Income | $80.91M↓ | $104.75M↑ | $16.46M↓ | $137.28M↑ | $67.09M |
| Net Income | $39.85M↓ | $44.96M↑ | -$23.48M↓ | $72.95M↑ | $41.38M |
Peer Comparison
JNJUNHPFE
Fundamentals
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, or...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.12B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
8.33
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
451,296
Recent News
Do Options Traders Know Something About Ardent Health Stock We Don't?
Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?
Ardent Health, a major U.S. hospital operator, reported fresh insider buying amid a year of notable share price declines.
Spotlight On Undervalued Small Caps With Insider Activity In June 2026
Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with anticipated earnings growth of 17% per annum in the coming years. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and exhibit insider activity can offer intriguing opportunities for investors seeking to navigate current market conditions.
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative?
Ardent Health has appointed former Chief Operating Officer Dave Caspers as President and Chief Executive Officer, and to its board, succeeding Marty Bonick following the company’s post-IPO transformation. This leadership shift places a seasoned operator of large-scale, tech-enabled healthcare systems at the helm, with direct oversight of Ardent’s IMPACT margin and care transformation program. We’ll now examine how Caspers’ elevation from COO to CEO could influence Ardent Health’s investment...
A Look At Ardent Health (ARDT) Valuation As New CEO Dave Caspers Takes The Helm
Leadership change and what it signals for Ardent Health stock Ardent Health (ARDT) has moved into the spotlight after appointing former Chief Operating Officer Dave Caspers as President, Chief Executive Officer, and board member, succeeding long time leader Marty Bonick. The board is tying this leadership shift to Ardent’s existing operating and growth plans, with Caspers continuing to oversee the IMPACT program, which targets margins, performance, agility, and care transformation across the...